15 reports

  • Infectious Disease
  • Malaria
  • Vaccine
  • United States
  • GlobalData's company
  • DESIGNMEDIX, INC. - PIPELINE BY INDICATION, 2015

This report is a licensed product and is not to be photocopied DesignMedix, Inc. has promising clinical drug candidates for ## major therapeutic areas, Gastrointestinal and Infectious Disease.

  • Malaria
  • United States
  • World
  • Product Initiative
  • DesignMedix

The agreement enables the parameters to build a specialist company in the field of gastrointestinal pharmaceuticals.

  • Cancer
  • Malaria
  • Japan
  • United States
  • Eisai Co., Ltd.
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H1 2017 (CONTD..1), H1 2017
  • MALARIA - PIPELINE BY ZYDUS CADILA HEALTHCARE LTD, H1 2017

It also provides antibiotics used for treatment of diseases such as vascular diseases, deep venous thrombosis and gastrointestinal tract diseases.

  • Malaria
  • Research And Development
  • United States
  • World
  • Product Initiative
  • Cerebral (Fatal) Malaria - Pipeline by Eisai Co Ltd, H2 2016

The company' s franchise areas in research include neurology, oncology, vascular and immunological reaction, gastrointestinal disorders, and musculoskeletal diseases.

  • Malaria
  • Pathology
  • World
  • Product Initiative
  • Eisai Co., Ltd.

DESIGNMEDIX INC - PHARMACEUTICALS & HEALTHCARE - DEALS AND ALLIANCES PROFILE DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea.

  • Malaria
  • United States
  • Company
  • Deals & Alliance
  • DesignMedix
  • GENEDRIVE - MALARIA ASSAY - PRODUCT DESCRIPTION
  • GENEDRIVE - MALARIA ASSAY - PRODUCT STATUS

It specializes in the marketing of epithelial stem cells in the areas of oncology, gastrointestinal diseases and dermatological applications.

  • Clinical Trial
  • Malaria
  • Point Of Care Testing
  • United States
  • GlobalData's company
  • Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture
  • Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture

Cadila' s products find application in the treatment of disease related to gastrointestinal, cardiovascular, women' s healthcare, respiratory, pain management, cancer, inflammation and neurology, among others.

  • Malaria
  • Pharmaceutical
  • United States
  • Company Operations
  • GlobalData's company

Report covers products from therapy areas Oncology, Infectious Disease and Gastrointestinal which include indications Malaria, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Breast Cancer, Colon Cancer, Hepatocel

  • Malaria
  • Therapy
  • World
  • Product Initiative
  • Domainex Ltd
  • Clinical Trial profile. 367 Trial Title
  • Clinical Trial Profile Snapshots

Gastrointestinal Complications Superiority of ArTiMist Versus Quinine in Children with Severe Malaria GDCT## NCT##, ART## Infectious Disease Malaria Completed Phase III Interventional artemether Proto Pharma Pvt.

  • Clinical Trial
  • Infectious Disease
  • Malaria
  • World
  • GlaxoSmithKline plc
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H2 2016 (CONTD..1)
  • MALARIA - PIPELINE BY MERLION PHARMACEUTICALS PTE LTD, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Malaria
  • Vaccine
  • United States
  • Company
  • Product Initiative

(MERIDIAN) MANUFACTURES DIAGNOSTIC TEST KITS FOR RESPIRATORY, GASTROINTESTINAL, VIRAL AND PARASITIC INFECTIOUS DISEASES.

  • Infectious Disease
  • Malaria
  • United States
  • Company Financials
  • Meridian Bioscience Europe SA

The most common adverse events reported in the Phase I clinical trials were related to the central nervous system and the gastrointestinal system.

  • Malaria
  • R&D
  • Research And Development
  • United States
  • Eisai Co., Ltd.

Gastrointestinal, Infectious Disease, Musculoskeletal Disorders, Oncology, Respiratory, Immunology, Metabolic Disorders, Dermatology and Ear Nose Throat Disorders.

  • Malaria
  • R&D
  • Research And Development
  • United States
  • Cellceutix Corporation

Budesonide (Entocort, Entocort EC) is a gastrointestinal agent.

  • Cancer
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC